Related Experiment Video
Updated: Jun 26, 2026
07:35
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Adult issues in phenylketonuria
M P A Hoeks1, M den Heijer, M C H Janssen
1Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, the Netherlands.
The Netherlands Journal of Medicine
|January 22, 2009
Summary
Phenylketonuria (PKU) management in adults requires attention to new challenges like vitamin deficiencies and osteoporosis. This review offers clinical guidelines for understanding and managing adult PKU effectively.
Area of Science:
- Metabolic disorders
- Genetics
- Clinical nutrition
Background:
- Phenylketonuria (PKU) is an inherited metabolic disease.
- Dietary intervention prevents intellectual disability in early-onset PKU.
- Adults with PKU face unique health issues.
Purpose of the Study:
- To provide clinical guidelines for managing adult PKU.
- To address emerging health concerns in adult PKU patients.
- To enhance clinician understanding of long-term PKU management.
Main Methods:
- Literature review on adult PKU management.
- Synthesis of current clinical practices and research findings.
- Development of evidence-based recommendations.
Main Results:
- Adult PKU presents challenges including vitamin deficiencies, osteoporosis, and maternal PKU syndrome.
- Long-term dietary adherence and monitoring are crucial.
- Multidisciplinary care is essential for optimal outcomes.
Conclusions:
- Effective management of adult PKU requires addressing specific adult-onset complications.
- Clinicians need updated guidelines to manage PKU beyond childhood.
- Proactive monitoring and intervention can mitigate risks in adult PKU patients.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...